Influence of dirlotapide, a microsomal triglyceride transfer protein inhibitor, on the digestibility of a dry expanded diet in adult dogs

Journal of Veterinary Pharmacology and Therapeutics

Volumn 30, Issue SUPPL. 1, 2007, Pages 66-72

  Kirk, C A ^a,d   Boucher, J F ^b   Sunderland, S J ^c   Wren, J A ^b  

^a UNIVERSITY OF TENNESSEE   (United States)

^b PFIZER INC   (United States)

^c ZOETIS   (United States)

^d UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIRLOTAPIDE; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN INHIBITOR; PLACEBO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; APPETITE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEFECATION HABIT; DIET; DIET RESTRICTION; DIGESTION; DOG; DRUG EFFECT; FECES; FEMALE; FOOD INTAKE; MALE; NONHUMAN; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANIMAL FEED; ANIMALS; ANTI-OBESITY AGENTS; CARBAMATES; CARRIER PROTEINS; DIET; DIGESTION; DOG DISEASES; DOGS; DOUBLE-BLIND METHOD; FEMALE; INDOLES; MALE; OBESITY; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

CANIS FAMILIARIS;

EID: 34249826929     PISSN: 01407783     EISSN: 13652885     Source Type: Journal    
DOI: 10.1111/j.1365-2885.2007.00856.x     Document Type: Article

References (25)

1. AAFCO (2003). Official Publication of the Association of American Feed Control Officials, Atlanta, Georgia, USA.
2. Acharya, N.V., Wilton, L.V. Shakir, S.A. (2006) Safety profile of orlistat: results of a prescription-event monitoring study. International Journal of Obesity (London), 30, 1645 1652.
3. Aggarwal, D., West, K.L., Zern, T.L., Shrestha, S., Vergara-Jimenez, M. Fernandez, M.L. (2005) JTT-130, a microsomal triglyceride transfer protein (MTP) inhibitor lowers plasma triglyceride and LDL cholesterol concentrations, without increasing hepatic triglycerides in guinea pigs. BMC Cardiovascular Disorders, 5, 1 8.
4. Bays, H. Stein, E.A. (2003) Pharmacotherapy for dyslipidaemia-current therapies and future agents. Expert Opinion on Pharmacotherapy, 4, 1901 1938.
5. Chandler, C.E., Wilder, D.E., Pettini, J.L., Savoy, Y.E., Petras, S.F., Chang, G., Vincent, J. Harwood, H.J. (2003) CP-346086: an MTP inhibitor that lowers plasma cholesterol and triglycerides in experimental animals and in humans. Journal of Lipid Research, 44, 1887 1901.
6. Diez, M., Nguyen, P., Jeusette, I., Devois, C., Istasse, L. Biourge, V. (2002) Weight loss in obese dogs: evaluation of a high-protein, low-carbohydrate diet. Journal of Nutrition, 132, 1685S 1687S.
7. German, A.J. (2006) The growing problem of obesity in dogs and cats. Journal of Nutrition, 136, 1940S 1946S.
8. Gordon, D.A. Jamil, H. (2000) Progress towards understanding the role of microsomal triglyceride transfer protein in apolipoprotein-B lipoprotein assembly. Biochimica et Biophysica Acta, 1486, 72 83.
9. Gossellin, J., Peachey, S., Sherington, J., Rowan, T.G. Sunderland, S.J. (2007) Evaluation of dirlotapide for sustained weight loss in overweight Labrador retrievers. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 55 65.
10. Greenway, F.L. Caruso, M.K. (2005) Safety of obesity drugs. Expert Opinion on Drug Safety, 4, 1083 1095.
11. Hand, M.S. Novotny, B.J. (2002) Pocket Companion to Small Animal Nutrition, 4th edn, p. 5. Mark Morris Institute, Topeka, Kansas, USA.
12. Hickman, M.A. (2005) Pharmacological Therapies for Obesity. 23rd Proceedings of the American College of Veterinary Internal Medicine Forum, Baltimore, Maryland, USA, pp. 1 3. Available at: http://www.vin.com/acvim/2006/.
13. Laflamme, D. (1997) Development and validation of a body condition score system for dogs. Canine Practice, 22, 10 15.
14. Li, J., Bertinato, P., Cheng, H., Cole, B.M., Bronk, B.S., Jaynes, B.H., Hickman, A., Haven, M.L., Kolosko, N.L., Barry, C.J. Manion, T.B. (2006) Discovery of potent and orally active MTP inhibitors as potential anti-obesity agents. Bioorganic & Medicinal Chemistry Letters, 16, 3039 3042.
15. McDuffie, J.R., Calis, K.A., Booth, S.L., Uwaifo, G.I. Yanovski, J.A. (2002) Effects of orlistat on fat-soluble vitamins in obese adolescents. Pharmacotherapy, 22, 814 822.
16. McGreevy, P.D., Thompson, P.C., Pride, C., Fawcett, A., Grassi, T. Jones, B. (2005) Prevalence of obesity in dogs examined by Australian veterinary practices and the risk factors involved. Veterinary Record, 156, 695 702.
17. Melia, A.T., Koss-Twardy, S.G. Zhi, J. (1996) The effect of orlistat, an inhibitor of dietary fat absorption, on the absorption of vitamins A and E in healthy volunteers. Journal of Clinical Pharmacology, 36, 647 653.
18. Shoulders, C.C. Shelness, G.S. (2005) Current biology of MTP: implications for selective inhibition. Current Topics in Medicinal Chemistry, 5, 283 300.
19. Stanley, S., Wynne, K. Bloom, S. (2004) Gastrointestinal satiety signals: III. Glucagon-like peptide 1, oxyntomodulin, peptide YY, and pancreatic polypeptide. American Journal of Physiology - Gastrointestinal & Liver Physiology, 286, G693 G697.
20. Wetterau, J.R., Aggerbeck, L.P., Bouma, M.E., Eisenberg, C., Munck, A., Hermier, M., Schmitz, J., Gay, G., Rader, D.J. Gregg, R.E. (1992) Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science, 258, 999 1001.
21. Wetterau, J.R., Gregg, R.E., Harrity, T.W., Arbeeny, C., Cap, M., Connolly, F., Chu, C.H., George, R.J., Gordon, D.A., Jamil, H., Jolibois, K.G., Kunselman, L.K., Lan, S.J., Maccagnan, T.J., Ricci, B., Yan, M., Young, D., Chen, Y., Fryszman, O.M., Logan, J.V., Musial, C.L., Poss, M.A., Robl, J.A., Simpkins, L.M., Slusarchyk, W.A., Sulsky, R., Taunk, P., Magnin, D.R., Tino, J.A., Lawrence, R.M., Dickson, J.K. Biller, S.A. (1998) An MTP inhibitor that normalizes atherogenic lipoprotein levels in WHHL rabbits. Science, 282, 751 754.
22. Wren, J.A., King, V.L., Campbell, S.L. Hickman, M.A. (2007a) Biologic activity of dirlotapide, a novel microsomal triglyceride transfer protein inhibitor, for weight loss in obese dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 33 42.
23. Wren, J.A., King, V.L., Krautmann, M.J., Gossellin, J., Kerlin, R.L., Hickman, M.A. Schmahai, T.J. (2007b) The safety of dirlotapide in dogs. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 43 54.
24. Wren, J.A., Ramudo, A.A., Campbell, S.L., King, V.L., Eagleson, J.S., Gossellin, J. Sunderland, S.J. (2007c) Efficacy and safety of dirlotapide in the management of obese dogs evaluated in two placebo-controlled, masked clinical studies in North America. Journal of Veterinary Pharmacology and Therapeutics, 30 (Suppl. 1), 81 89.
25. Zhi, J., Moore, R. Kanitra, L. (2003) The effect of short-term (21-day) orlistat treatment on the physiologic balance of six selected macrominerals and microminerals in obese adolescents. Journal of the American College of Nutrition, 22, 357 362.